Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
120mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Your oncologist may prescribe Lumakras for treating certain types of non-small cell lung cancer (NSCLC). Lumakras is indicated to treat locally advanced or metastatic NSCLC with a specific genetic mutation called KRAS G12C.
Lumakras works by inhibiting KRAS G12C, a mutated protein that promotes the growth of cancer cells. Before using Lumakras, your doctor will perform a genetic test to determine if you have the KRAS G12C mutation.
Fact Table | |
Formula |
C30H30F2N6O3 |
License |
US DailyMed |
Bioavailability |
- |
Legal status |
Rx-Only |
Chemical Name |
Sotorasib |
Elimination half-life |
5 hours |
Dosage (Strength) |
120mg |
Pregnancy |
Consult Doctor |
Brands |
Lumakras |
Protein binding |
- |
PubChem CID |
137278711 |
MedlinePlus |
a621036 |
ChEBI |
178199 |
ATC code |
L01XX73 |
DrugBank |
DB15569 |
KEGG |
D12055 |
Routes of administration |
By mouth |
The usual dosage of Lumakras is 960 mg (eight tablets) by mouth once daily, with or without food.
Do not crush, chew, or break Lumakras tablets. Swallow them whole with water.
The active ingredient in Lumakras is Sotorasib.
Common drug interactions can occur with the following:
Tell your doctor if you have a history of liver or kidney disease. Your oncologist will need to increase monitoring for liver problems during the first three months of treatment.
Lumakras may interact with other medications, including certain antibiotics and antifungals. It is important to inform your oncologist of all your medications before starting treatment with Lumakras.
Your oncologist should monitor for new or worsening pulmonary systems and consider stopping Lumakras if these symptoms develop.
Common adverse reactions may include: